Роль чинників росту у розвитку доброякісної гіперплазії передміхурової залози та їх зв'язок із метаболічним синдромом

М. Л. Кирилюк, Ф. І. Костєв, А. В. Підаєв, С. С. Шаталюк

Повний текст:

PDF

Посилання


Возіанов О. Ф. Роль факторів росту в патогенезі гіперплазії простати / О. Ф. Возіанов, С. П. Пасічников, А. О. Андреєв // Урологія. – 1999. – № 3. – С. 93-98.

Гладкова А. И. Роль фактора роста в мужской репродукции. Сообщение 1. Инсулиноподобные факторы роста / А. И. Гладкова // Проблемы эндокринной патологии. – 2005. – № 2. – С. 76-86.

Зезеров В. Г., Северин Е. С. Молекулярные механизмы онкогенеза предстательной железы / В. Г. Зезеров, Е. С. Северин // Вестник РАМН. – 1998. – №5. – С. 29-35.

Копнер Р. Б. Инсулиноподобные факторы роста , или соматомедины, - новое семейство пептидных биорегуляторов / Р. Б. Копнер, А. А. Булатов // Успехи современной биологии. – 1984. – Т. 97, №2. – С. 225-240.

Лучицький Є. В. Метаболічний синдром та цукровий діабет 2 типу у чоловіків: роль андронодефіцитного стану / Є. В. Лучицький // Інноваційні технології в сучасній ендокринології: 52 щорічна наук.-практ. конф. з міжнародною участю : зб. лекцій. – Харків, 2008. – С. 67-74.

Переверзев А. С. Аденома предстательной железы / А. С. Переверзев, Н. Ф. Сергиенко. – К.: Ваклер. – C. 277.

Роль тестостерона в регуляции экспрессии генов некоторых факторов пролиферации / А. В. Печерский, О. Б. Лоран, В. И. Печерский [и др.] // Цитология. – 2006. – №48(10). – С. 856-861.

Aaronson N.K. Quality of life: what is it? How should it be measured? / N.K. Aaronson // Oncology. – 1998. – Vol. 2. – P. 69-74.

Alteration in the pulsatile properties of circulating growth hormone concentrations during puberty in boys / P.M. Martha, A. D. Rogol, J. D. Veldhuis [et al.] // The Journal of clinical endocrinology and metabolism. -1989. – Vol. 69, №3. – P. 563-570. https://doi.org/10.1210/jcem-69-3-563

Analysis of serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in benign prostatic hyperplasia / J.P. Yu, X.M. Wu , J.G. Chen [et al.] // Zhonghua Nan Ke Xue. – 2003. – Vol. 9(5). – P. 341-343.

Circulating insulin-like growth factor-I and benign prostatic hyperplasia – a prospective study / P. Stattin, R. Kaaks, E. Riboli [et al.] // Scandinavian journal of urology and nephrology. – 2001. – Vol. 35(2). – P. 122-126. https://doi.org/10.1080/003655901750170506

Cohen P. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues / P. Cohen, S.E. Nunn, D.M. Peehl // The Journal of endocrinology. – 2000. – Vol. 164(2). – P. 215-223. https://doi.org/10.1677/joe.0.1640215

Delsite R. Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: A role in selective neurotrophin stimulation of prostate epithelial cell growth / R. Delsite, D. Djakiew // Prostate. – 1999. – Vol. 41, №1. – P. 39-48. https://doi.org/10.1002/(sici)1097-0045(19990915)41:1<39::aid-pros6>3.0.co;2-e

Differential immunoreactivity of transforming growth factor-alpha in benign, dysplastic and malignant prostatic tissues / C.N. Robertson, K.M. Robertson, A.G. Herberg [et al.] // Surgical oncology. – 1994. – Vol. 3. – P. 234-242. https://doi.org/10.1016/0960-7404(94)90039-6

Differentiation effect of keratinocyte growth factor (KKGF) on aromatase activity in cultured canine prostatic epithelial cell / H. Canatan, F. Shidaifat, S.K. Kulp [et al.] // Endocrine research. – 1997. – Vol. 23, №4. – P. 311-323. https://doi.org/10.1080/07435809709031860

Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? / V.C. Mishra, D.J. Allen, C. Nicolaou [et al.] // BJU. – 2007. – Vol. 100, № 2. – P. 327-331. https://doi.org/10.1111/j.1464-410x.2007.06910.x

Donjacour A.A. FGF-10 plays an essential role in the growth of the fetal prostate / A.A. Donjacour, A.A. Thomson, G.R. Cunha // Developmental biology. – 2003. – Vol. 261, №1. – P. 39-54. https://doi.org/10.1016/s0012-1606(03)00250-1

Expression and effect of insulin-like growth factor I on rat fetal Leydig cell function and differentiation / V. Rouiller, L. Lecerf, C. Gautier [et al.] / / Endocrinology. – 1998. – Vol. 139, №6. – P. 2926-2934. https://doi.org/10.1210/endo.139.6.6035

Garde S.V. Immunopeoxidase localization of prostates inhibin peptide in human, monkey, dog, and rat prostates / S.V. Garde, A.R. Sheth // The Anatomical record. – 1989. – Vol. 223, №2. – P. 181-184. https://doi.org/10.1002/ar.1092230210

Groham C.W. Distribution of nerve growth factorlike protein and nerve growth factor receptor in human prostatic hyperplasia and prostatic adenocarcinoma / C.W. Groham, J.H. Lynch, D. Djaldew // The Journal of urology. – 1992. – Vol. 147. – P. 1444-1447.

Growth hormone directly affects the function of the different lobes of the rat prostate / E. Reiter, O. Kesha, B. Henrruy [et al.] // Endocrinology. – 1995. -Vol. 136, №8. – P. 3338-3345. https://doi.org/10.1210/endo.136.8.7628369

Hormonal modulation of invitro biosynthesis of inhibin like peptide by human prostate. / G.R. Vanage, M.A. Phadke A.H. Bandivdekar [et al.] // Andrologia. – 1990. – Vol. 22, №l. – P. 7-11. https://doi.org/10.1111/j.1439-0272.1990.tb01932.x

Insulin-like growth factor (IGF)-I controls prostate fibromuscular development: IGF-I inhibition prevents both fibromuscular and glandular development in eugonadal mice / D.L. Kleinberg, W. Ruan, D. Yee [et al.] // Endocrinology. – 2007. – Vol. 148(3). – P. 1080-1088. https://doi.org/10.1210/en.2006-1272

Insulin-like growth factors and risk of benign prostatic hyperplasia / A.P. Chokkalingam, Y.T. Gao, J. Deng [et al.] // Prostate. – 2002. – Vol. 52(2). – P. 98-105. https://doi.org/10.1002/pros.10096

Itoh N. Developmental and hormonal regulation of transforming growth factor-? and epidermal growth factor receptor gene expression in insolated prostatic epithelial and stromal cells / N. Itoh, U. Patel, M.K. Skinner // Endocrinology. – 1998. – Vol. 139, №3. – P. 1369-1377. https://doi.org/10.1210/en.139.3.1369

Kharbanda K. Further studies on the synthesis and secretion of inhibin-like material by rat ventral prostate explants in vitro / K. Khrbanda, S. Duraiwami // Prostate. – 1990. – Vol. 16, №2. – P. 163-172. https://doi.org/10.1002/pros.2990160207

Localization of epidermal growth factor receptors in human prostate by biochemical and immunocytochemical methods / S.Q. Maddy, G.D. Chisholm, R.A. Hawkins [et al.] // The Journal of endocrinology. – 1987. – Vol. 113. – P. 147-153. https://doi.org/10.1677/joe.0.1130147

Matsuda T. Relation between benign prostatic hyperplasia and obesity and estrogen / T. Matsuda, H. Abe, K. Suda // Rinsho byori. – 2004. – Vol. 52, №4. – P. 291-294.

Monti S. Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgen / S. Monti, F. Di Silverio, S. Lanzara // Steroids. – 1998. – Vol. 63(5-6). – P. 362-366. https://doi.org/10.1016/s0039-128x(98)00034-8

Nickerson T. Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4 and 5 / T. Nickerson, M. Pollak, H. Huynh // Endocrinology. – 1998. – Vol. 139, №2. – P. 807-810. https://doi.org/10.1210/endo.139.2.5912

Opposing actions of TGF-beta-1 and FGF-2 on growth, differentiation and extracellular matrix accumulation in prostatic stromal cells / N.A. Cross, S.V. Reid, A.J. Harvey [et al.] // Growth Factors. – 2006. – Vol. 24(4). – P. 233-41. https://doi.org/10.1080/08977190600976501

Paracrine regulation of testicular function: growth factors as paracrine regulation of testicular function / J.M. Saez, O. Avallet, M. Vigier [et al.] // 31 Int. Congr. Physiol. Sci, Helsinki. – Oulu, 1989. – P. 17-19.

Pollan M.C. Growth factor expression in early stages of benign prostatic hyperplasia upon exposure to sustained delivery of androgens / M.C. Pollan, H.A. Benghuzzi, M. Tucci // Biomedical sciences instrumentation. – 2003. – Vol. 39. – P. 329-334.

Profiling molecular targets of TGF-beta1 in prostate fibroblast – to myofibroblast transdifferentiation / G. Untergasser, R. Gander, C. Lilg [et al.] // Mechanisms of ageing and development. – 2005. – Vol. 126(1). – P. 59-69. https://doi.org/10.1016/j.mad.2004.09.023

Regional expression of transforming growth factor-alpha in rat ventral prostate during postnatal development, after androgen ablation, and after androgen replacement / S. Banerjee, P.P. Banerjee, R.B. Zirtkin [et al.] // Endocrinology. – 1998. – Vol. 155, №6. – P. 3005-3013. https://doi.org/10.1210/endo.139.6.6060

Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens / S. Monti, F. Di Silverio, R. Iraci [et al.] // The Journal of clinical endocrinology and metabolism. – 2001. – Vol. 86(4). – P. 1700-1706. https://doi.org/10.1210/jcem.86.4.7413

Story M.T. Positive and negative modulators of prostate cell proliferations / M.T. Story // Biomedicine & pharmacotherapy. – 1994. – Vol. 48, № 1. – P. 359-415. https://doi.org/10.1016/s0753-3322(09)80007-3

Transforming growth factor-β induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells / M.L. Gerdes, T.D. Dang, M. Larsen [et al.] // Endocrinology. – 1998. – Vol. 139, № 8. – P. 5369-5377. https://doi.org/10.1210/en.139.8.3569

Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human, cultured, prostatic stromal cell exposed to high concentrations of estradiol / P. Smith, N.P. Rhodes, Y. Ke [et al.] // Prostate cancer and prostatic diseases. – 2002. – Vol. 5, №2. – P. 105-110. https://doi.org/10.1038/sj.pcan.4500571

Zhang Hong. Insulin-like growth factor 1 – mediated degradation of insulin receptor substrate I is inhibited by epidermal growth factor in prostate epithelial cells / Zhang Hong // The Journal of biological chemistry. – 2000. -Vol. 275, №29. – P. 22558-22562. https://doi.org/10.1074/jbc.m000412200


Пристатейна бібліографія ГОСТ






DOI: https://doi.org/10.24026/1818-1384.3(40).2012.83187



Creative Commons License
Ця робота ліцензована Creative Commons Attribution-NonCommercial 4.0 International License.

© Клінічна ендокринологія та ендокринна хірургія.

ISSN: 1818-1384 (Print), e-ISSN: 2519-2582, DOI: 10.24026/1818-1384.

При копіюванні активне посилання на матеріал обов'язкове.

Flag Counter